At a glance
Type: Incretin dual-agonist peptide
Category: Metabolic & incretin research
Alternate names: LY3298176, dual GIP/GLP-1 agonist peptide
Historical context
Developed as LY3298176; clinical literature describes pharmaceutical products under specific indications. VaultLabs research-grade material is a separate laboratory reference supply with independent lot documentation.
Active research areas
Dual incretin receptor pharmacology
Comparative GLP-1 / GIP agonist assays
Analytical characterisation of large incretin peptides
Material availability
VaultLabs catalog SKUs: tirzepatide-30mg — view product pages for current AED pricing and lot documentation.
COA verification available per batch when published to the documentation portal.
Research-only supply
Catalog documentation describes material identity and lot data only — not clinical outcomes or personal use.
All VaultLabs materials are supplied strictly for in vitro laboratory and research use. Not for human consumption, medical use, or personal application.